We are live on ! Find out more
AP

AtonRa Partners Portfolio holdings

AUM $50.2M
1-Year Est. Return 47.76%
This Fund
S&P 500
This Quarter Est. Return
+7.93%
1 Year Est. Return
+47.76%
3 Year Est. Return
+48.32%
5 Year Est. Return
10 Year Est. Return
AUM
$224M
AUM Growth
+$20.4M
Cap. Flow
+$27.3M
Cap. Flow %
12.16%
Top 10 Hldgs %
22.39%
Holding
140
New
33
Increased
51
Reduced
24
Closed
32

Top Buys

Rank Stock Value
1
SDGR icon
Schrodinger
SDGR
+$3.33M
2
CRWD icon
CrowdStrike
CRWD
+$3.32M
3
RIOT icon
Riot Platforms
RIOT
+$2.94M
4
ZS icon
Zscaler
ZS
+$2.92M
5
SPCE icon
Virgin Galactic
SPCE
+$2.84M

Top Sells

Rank Stock Value
1
SPLK
Splunk Inc
SPLK
+$3.75M
2
TME icon
Tencent Music
TME
+$3.44M
3
AMZN icon
Amazon
AMZN
+$3.18M
4
XLNX
Xilinx Inc
XLNX
+$2.35M
5
BR icon
Broadridge
BR
+$2.23M

Sector Composition

Rank Sector Weight
1 Technology 41.29%
2 Healthcare 36.47%
3 Financials 8.77%
4 Industrials 5.95%
5 Consumer Discretionary 3.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIIB icon
101
Biogen
BIIB
$29.9B
$774K 0.35%
+2,767
New +$746K
DDD icon
102
3D Systems Corp
DDD
$420M
$700K 0.31%
+25,514
New +$843K
GWRE icon
103
Guidewire Software
GWRE
$11.5B
$564K 0.25%
5,551
-16,498
-75% -$1.92M
BMRN icon
104
BioMarin Pharmaceuticals
BMRN
$11.5B
$561K 0.25%
7,429
+1,507
+25% +$123K
CBAY
105
DELISTED
Cymabay Therapeutics
CBAY
$506K 0.23%
111,525
+23,544
+27% +$127K
AMWL icon
106
American Well
AMWL
$181M
$501K 0.22%
+1,443
New +$782K
MCRB icon
107
Seres Therapeutics
MCRB
$48M
$448K 0.2%
1,088
+243
+29% +$112K
AAPL icon
108
Apple
AAPL
$4.89T
-5,266
Closed -$699K
AKAM icon
109
Akamai
AKAM
$16.8B
-9,246
Closed -$971K
AMZN icon
110
Amazon
AMZN
$2.5T
-19,520
Closed -$3.18M
BIO icon
111
Bio-Rad Laboratories Class A
BIO
$8.42B
-2,289
Closed -$1.33M
BR icon
112
Broadridge
BR
$17.2B
-14,582
Closed -$2.23M
DDOG icon
113
Datadog
DDOG
$87.9B
-5,910
Closed -$582K
DHR icon
114
Danaher
DHR
$135B
-3,617
Closed -$712K
ESPR
115
DELISTED
Esperion Therapeutics
ESPR
-16,139
Closed -$420K
EXEL icon
116
Exelixis
EXEL
$13.9B
-103,080
Closed -$2.07M
GOOGL icon
117
Alphabet (Google) Class A
GOOGL
$3.91T
-7,120
Closed -$624K
HQY icon
118
HealthEquity
HQY
$7.91B
-9,802
Closed -$683K
IRTC icon
119
iRhythm Holdings
IRTC
$3.59B
-3,513
Closed -$833K
JKHY icon
120
Jack Henry & Associates
JKHY
$10.7B
-5,632
Closed -$912K
LDOS icon
121
Leidos
LDOS
$14.1B
-11,394
Closed -$1.2M
LX
122
LexinFintech Holdings
LX
$244M
-57,544
Closed -$386K
MSFT icon
123
Microsoft
MSFT
$2.84T
-3,257
Closed -$724K
OMCL icon
124
Omnicell
OMCL
$1.86B
-11,655
Closed -$1.4M
QNCX icon
125
Quince Therapeutics
QNCX
$17.5M
-95
Closed -$528K

Similar funds

AtonRa Partners's Q1 2021 Portfolio in Review

As of Q1 2021, AtonRa Partners held 140 positions worth $224M, up 10% from $204M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

AtonRa Partners deployed $27.3M of net new capital in Q1 2021, opening 33 new positions and adding to 51 existing holdings. Its largest new stake was Schrodinger: 37,089 shares worth $2.83M.

By sector, the portfolio is most concentrated in Technology at 41% of assets, down from 43% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Guidewire Software, an estimated $1.92M trimmed.

  • AtonRa Partners's largest Q1 2021 buy was Schrodinger: 37,089 shares worth $2.83M.
  • AtonRa Partners added most to Virgin Galactic in Q1 2021, an estimated $2.84M increase.
  • AtonRa Partners's biggest Q1 2021 reduction was Guidewire Software, cutting an estimated $1.92M.
  • AtonRa Partners fully exited Splunk Inc in Q1 2021, selling an estimated $3.75M.
  • AtonRa Partners's ten largest holdings make up 22% of its $224M portfolio in Q1 2021.
  • AtonRa Partners opened 33 new positions and closed 32 in Q1 2021.
  • AtonRa Partners's portfolio value rose 10% quarter-over-quarter to $224M.

Based on AtonRa Partners's 13F filing for Q1 2021, filed 17 May 2021.